Sinonasal Malignancy and Orbital Exenteration Sparing Cancer Surgery

Camilo Reyes; Mihir Patel; C. Arturo Solares

doi:10.1055/s-0040-1713937

Journal of Neurological Surgery Part B: Skull Base, Inhaltsverzeichnis

J Neurol Surg B Skull Base 2020; 81(04): 369-375
DOI: 10.1055/s-0040-1713937

Typical Orbital Pathologies

Review Article

Sinonasal Malignancy and Orbital Exenteration Sparing Cancer Surgery

Camilo Reyes

¹Division of Rhinology and Endoscopic Skull Base Surgery, Department of Otolaryngology - Head and Neck Surgery, Augusta University, Augusta, Georgia, United States

,

Mihir Patel

²Department of Otolaryngology - Head and Neck Surgery, Winship Cancer Institute at Emory University, Emory University, Atlanta, Geogia, United States

,

C. Arturo Solares

²Department of Otolaryngology - Head and Neck Surgery, Winship Cancer Institute at Emory University, Emory University, Atlanta, Geogia, United States

› Institutsangaben

Abstract

This article reviews the most common locations and natural history of sinonasal carcinomas. It also reviews surgical indications and current evidence regarding adjuvant and neoadjuvant therapies. In the past, orbital clearance was generally done for ethmoid and maxillary cancers, even without a marked neoplastic infiltration; however, such indications have changed in the recent years due to advances in our understanding of the disease, as well as new chemotherapeutic and radiotherapy protocols. Surgical resection of tumors close to the orbit exhibits the challenging task of balancing treatment goals and patient's desires.

Keywords

periorbita - periorbital fat - extraocular muscles - maxillary sinus carcinoma - squamous cell - carcinoma - paranasal sinuses - orbital exenteration

Volltext

Referenzen

References
1 Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 2013; 24 (01) 39-49
2 Reyes C, Mason E, Solares CA, Bush C, Carrau R. To preserve or not to preserve the orbit in paranasal sinus neoplasms: a meta-analysis. J Neurol Surg B Skull Base 2015; 76 (02) 122-128
3 Maroldi R, Farina D, Battaglia G, Maculotti P, Chiesa A. [Magnetic resonance and computed tomography compared in the staging of rhinosinusal neoplasms. A cost-effectiveness evaluation]. Radiol Med (Torino) 1996; 91 (03) 211-218
4 Eisen MD, Yousem DM, Loevner LA, Thaler ER, Bilker WB, Goldberg AN. Preoperative imaging to predict orbital invasion by tumor. Head Neck 2000; 22 (05) 456-462
5 Kim HJ, Lee TH, Lee HS, Cho KS, Roh HJ. Periorbita: computed tomography and magnetic resonance imaging findings. Am J Rhinol 2006; 20 (04) 371-374
6 Huang SH, O'Sullivan B. Overview of the 8th edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol 2017; 18 (07) 40
7 Suarez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004; 26 (02) 136-144
8 Imola MJ, Schramm Jr VL. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope 2002; 112 (8 Pt 1): 1357-1365
9 Iannetti G, Valentini V, Rinna C, Ventucci E, Marianetti TM. Ethmoido-orbital tumors: our experience. J Craniofac Surg 2005; 16 (06) 1085-1091
10 Wu X, Tang P, Qi Y. Management of the orbital contents in radical surgery for squamous cell carcinoma of the maxillary sinus. Chin Med J (Engl) 1995; 108 (02) 123-125
11 Carrau RL, Segas J, Nuss DW. et al. Squamous cell carcinoma of the sinonasal tract invading the orbit. Laryngoscope 1999; 109 (2 Pt 1): 230-235
12 Lund VJ, Howard DJ, Wei WI, Cheesman AD. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses--a 17-year experience. Head Neck 1998; 20 (02) 97-105
13 Wang EW, Zanation AM, Gardner PA. et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol 2019; 9 (S3): S145-S365
14 Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002; 112 (8 Pt 1): 1450-1455
15 Jiang GL, Tucker SL, Guttenberger R. et al. Radiation-induced injury to the visual pathway. Radiother Oncol 1994; 30 (01) 17-25
16 Bossi P, Farina D, Gatta G, Lombardi D, Nicolai P, Orlandi E. Paranasal sinus cancer. Crit Rev Oncol Hematol 2016; 98: 45-61
17 Itami J, Uno T, Aruga M, Ode S. Squamous cell carcinoma of the maxillary sinus treated with radiation therapy and conservative surgery. Cancer 1998; 82 (01) 104-107
18 Lee MM, Vokes EE, Rosen A, Witt ME, Weichselbaum RR, Haraf DJ. Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am 1999; 5 (04) 219-223
19 Nibu K, Sugasawa M, Asai M. et al. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 2002; 94 (05) 1476-1482
20 Björk-Eriksson T, Mercke C, Petruson B, Ekholm S. Potential impact on tumor control and organ preservation with cisplatin and 5-fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa. A prospective pilot study. Cancer 1992; 70 (11) 2615-2620
21 Hanna EY, Cardenas AD, DeMonte F. et al. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2011; 137 (01) 78-81
22 Ock CY, Keam B, Kim TM. et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med (Korean Assoc Intern Med) 2016; 31 (03) 570-578
23 Chen NX, Chen L, Wang JL. et al. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus. Jpn J Clin Oncol 2016; 46 (08) 727-734
24 Trief D, Gray ST, Jakobiec FA. et al. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus . Br J Ophthalmol 2016; 100 (02) 184-188
25 Lenzi R, Bleier BS, Felisati G, Muscatello L. Purely endoscopic trans-nasal management of orbital intraconal cavernous haemangiomas: a systematic review of the literature. Eur Arch Otorhinolaryngol 2016; 273 (09) 2319-2322